FIELD: medicine, narcology. SUBSTANCE: invention proposes to use hexapeptide Tyr-D-Ala-Gly-Phe-Leu-Arg for treatment of persons with compulsive inclination to narcotic of opiate group. Agent has no adverse effects, it does not cause dependency and allows to decrease arresting period of opium abstinent syndrome. EFFECT: enhanced effectiveness of agent. 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING THE CASES OF DRUG ADDICTION | 2003 |
|
RU2288717C2 |
METHOD OF NARCOMANIA TREATMENT | 2000 |
|
RU2197250C2 |
METHOD OF OPIUM NARCOMANIA TREATMENT | 1999 |
|
RU2192275C2 |
METHOD OF TREATING OPIUMISM | 1992 |
|
RU2026676C1 |
METHOD FOR TREATING NARCOMANIA CASES | 2005 |
|
RU2302227C2 |
METHOD FOR TREATING NARCOMANIA PATIENTS FOR ACUTE ABSTINENCE SYNDROME | 2001 |
|
RU2226408C2 |
AGENT FOR DRUG ADDICT TREATMENT | 2000 |
|
RU2162330C1 |
METHOD FOR TREATING AN ABSTINENTIAL SYNDROME AT HEROIN NARCOMANIA | 2000 |
|
RU2191019C2 |
METHOD FOR DIAGNOSTICS OF DEGREE OF OPIUM ABSTINENCE SYNDROME | 2000 |
|
RU2195158C2 |
METHOD FOR TREATING OPIUM NARCOMANIA | 2005 |
|
RU2290947C1 |
Authors
Dates
2000-07-20—Published
1997-07-28—Filed